Therapy Insight: fibromyalgia--a different type of pain needing a different type of treatment (Q34560547)

3 August 2017

1 reference

title

Therapy Insight: fibromyalgia--a different type of pain needing a different type of treatment (English)

1 reference

3 August 2017

0 references

2

Daniel J Clauw

1 reference

3 August 2017

Dina Dadabhoy

1

1 reference

3 August 2017

1 July 2006

1 reference

Nature Clinical Practice Rheumatology

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

7

1 reference

3 August 2017

364-372

1 reference

https://scigraph.springernature.com/pub.10.1038/ncprheum0221

3 August 2017

0 references

cites work

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

The prevalence and characteristics of fibromyalgia in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Population study of tender point counts and pain as evidence of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

More pain, more tender points: is fibromyalgia just one end of a continuous spectrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Chronic widespread pain in the population: a seven year follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Family study of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Spinal and supraspinal contributions to central sensitization in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

If you have to prove you are ill, you can't get well. The object lesson of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Pain catastrophizing and neural responses to pain among persons with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Do fibromyalgia patients display hypervigilance for innocuous somatosensory stimuli? Application of a body scanning reaction time paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Management of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Antidepressant treatment of fibromyalgia. A meta-analysis and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Evidence-based data on pain relief with antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Anticonvulsant drugs for acute and chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Prophylactic pharmacological treatment of chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Gulf War veterans' health: medical evaluation of a U.S. cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

A review of the evidence for overlap among unexplained clinical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Erratum: An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Multi-method assessment of experimental and clinical pain in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Management of chronic pain in whiplash injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Does the label "fibromyalgia" alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

A randomized controlled trial of citalopram in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Treatment of fibromyalgia with formula acupuncture: investigation of needle placement, needle stimulation, and treatment frequency

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0221

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0221

1 reference

PubMed ID

16932722

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

16932722